Abstract
Recently we reported that right ventricular failure (RVF) was reversed by chronic treatment with the α1A-adrenergic receptor (α1A-AR) agonist A61603 (PMID 30412439). Reversal of RVF involved an increased level of the mitochondrial anti-apoptotic protein Bcl-2, suggesting that protection of mitochondria played a role.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
